This website has been funded and developed by AbbVie and is intended for UK audiences only.

Taking control of your migraine journey

Being in the driver’s seat of your migraine journey starts with understanding how it impacts your life. But a key roadblock can be communicating your experience with your healthcare professional.

MyMAP may help you and your doctor get a clearer picture of your migraine experience to date.

This intuitive questionnaire enables you and your doctor to make decisions about your care together by evaluating how your migraine impacts your daily life. By working together with your doctor, you can decide on a management plan that is tailored to your needs and goals.

Seeking migraine care

No two migraine journeys are alike.

Understanding that your journey is specific to you is the first step towards personalised support and care.

Along this path, there are three key healthcare professionals you might interact with:

Nurse
Nurse

Nurses can provide support and help monitor your progress.

General practitioner
General practitioner (GP)

Your GP plays a central role in diagnosing your migraines as they assess your overall health and work closely with you to adjust your plan as needed.

Community pharmacist
Community pharmacist

Pharmacists can offer additional expert advice on the management of medications.1

Collaborating with your doctor

The collaboration between you and your doctor (also known as shared decision-making among healthcare professionals) is a common process, gaining more traction as people want to be involved in decisions about their health and care.2,3

This process brings together a medical professional’s expertise—such as treatment options, evidence, risks, and benefits—with your first-hand experience of living with migraine, as well as your preferences, personal circumstances, goals, values, and beliefs.4,5

MyMAP may help this collaboration by being a useful prompt for those living with migraine to record and share their experience during the appointment.

Dr David Watson’s story

Dr. David Watson

‘When a patient generates their MAP ahead of their appointment, it provides this wealth of information that can kickstart the consultation.’

Dr. David Watson, GP

Dr. David Watson, a GP based in Aberdeen, has dedicated his career to improving migraine care through both clinical practice and education.

Frustrated by the limitations of brief appointments, Dr. Watson explains how MyMAP may help patients convey the impact migraine has on their daily lives, leading to more personalised care. This gives both patients and doctors a shared-purpose, helping to have better conversations to improve their care.

By integrating MyMAP into his practice, Dr. Watson shares how it has made consultations more focused, helping him uncover the details that matter most to his patients. His experience highlights the value of patient preparation in supporting shared decision-making and delivering personalised, quality care.

Dr Watson’s experience using MyMAP

References

  1. 1. Community pharmacy — The Migraine Trust. Available from: https://migrainetrust.org/live-with-migraine/healthcare/community-pharmacy. [Last accessed: September 2024].
  2. 2. Care Quality Commission. Better care in my hands: a review of how people are involved in their care. Available from: https://www.cqc.org.uk/publications/themed-work/better-care-my-hands-review-how-people-are-involved-their-care. [Last accessed: September 2024].
  3. 3. NHS. About shared decision making. Available from: https://www.england.nhs.uk/personalisedcare/shared-decision-making/about/. [Last accessed: September 2024].
  4. 4. NHS. RightCare: Headache & Migraine Toolkit optimising headache and migraine system. Available from: https://www.england.nhs.uk/rightcare/wp-content/uploads/sites/40/2020/01/rightcare-headache-and-migraine-toolkit-v1.pdf. [Last accessed: September 2024].
  5. 5. NHS. Shared decision making summary guide. Available from: https://www.england.nhs.uk/wp-content/uploads/2019/01/shared-decision-making-summary-guide-v1.pdf. [Last accessed: September 2024].

UK-ABBV-240186
September 2024

May 2023 | UK-ABBV-230064

This website has been developed and funded by AbbVie and is intended for UK audiences only. This resource is not intended to provide or replace expert medical advice.

@2024 AbbVie Ltd. AbbVie House, Vanwall Business Park, Maidenhead, Berkshire, SL6 4UB. UK Telephone: +44 (0) 1628 561 090. All rights reserved. Registered number: 08004972

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of a medicine.